Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens

NCT01653847 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Failure With Renal Transplant

Interventions

DRUG: Tacrolimus with MMF
DRUG: Group 2: Tacrolimus with Everolimus.

Sponsor

Northwestern University

Collaborators

[object Object]